| 发明名称 |
Therapy for alpha-galactosidase a deficiency |
| 摘要 |
A therepeutic method whereby an individual suspected of having an alpha-galactosidase A deficiency, such as Fabry disease, is treated either with (1) human cells that have been genetically modified to overexpress and secrete human alpha-gal A, or (2) purified human alpha-gal A obtained from cultured, genetically modified human cells.
|
| 申请公布号 |
US6395884(B1) |
申请公布日期 |
2002.05.28 |
| 申请号 |
US20000543921 |
申请日期 |
2000.04.06 |
| 申请人 |
TRANSKARYOTIC THERAPIES, INC. |
发明人 |
SELDEN RICHARD F.;BOROWSKI MARIANNE;GILLISPIE FRANCES P.;KINOSHITA CAROL M.;TRECO DOUGLAS A.;WILLIAMS MELANIE D. |
| 分类号 |
A61K38/00;C07K14/61;C12N5/08;C12N9/40;C12P21/04;(IPC1-7):C07K1/00;C07K14/00;C12N15/63;C12P21/06 |
主分类号 |
A61K38/00 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
